Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOte Ads Regulatory News (OTES)

Share Price Information for Ote Ads (OTES)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 6.06274
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 0.00 (0.00%)
Open: 6.06274
High: 0.00
Low: 0.00
Prev. Close: 6.06274
OTES Live PriceLast checked at -
  • This share is an international stock.

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Response to the HCMC EU's approval of TKR disposal

30 Jul 2021 09:21

RNS Number : 0665H
Hellenic Telecomms Organization S A
30 July 2021
 

Response to

Hellenic Capital Market Commission letter

 

Athens, July 30, 2021 - Hellenic Telecommunications Organization S.A. ("OTE S.A." or the "Company"), following its announcement on 28.7.2021 and in response to the Hellenic Capital Market Commission relevant request for clarifications, dated 29-07-2021, on European Commission's (EC) conditional approval for the sale of Telekom Romania Communications S.A. ("TKR") to Orange, announces the following:

 

1) Following its investigation, the EC as it mentions in the related press release, found that the transaction between OTE and Orange Romania for the sale of the 54% stake OTE holds in TKR, as initially notified, would have raised serious competition concerns on the market for retail mobile telecommunications services. In particular, Orange would have acquired TKR's 30% minority shareholding in Telekom Romania Mobile Communications S.A (TKRM), one of its key competitors in the Romanian mobile market.

In order to address the aforementioned competition concerns, the parties committed to secure the divestment of TKR's 30% stake in TKRM to OTE, which currently holds 70% of TKRM. The EC has concluded that the proposed transaction, subject to the completion of the aforementioned remedy, would no longer raise competition concerns.

 

2) As announced on July 28, 2021, OTE intends to acquire this 30% stake from TKR subject to required approvals. Such acquisition would increase OTE's stake in TKRM to 99.99%, from 70% currently. The timetable of executing this acquisition will depend on EC approval both of OTE as a suitable purchaser and the divestment agreement. The consideration will be determined following a valuation to be performed by independent advisors. It is not expected to differ significantly from the net book value. OTE discloses relevant financial information on TKRM in its Annual Financial Statements:

https://www.cosmote.gr/otegroup_company/annualreport/2020/en/docs/FinancialReport2020English.pdf 

 

3) TKR divestment of its 30% stake in TKRM will have no impact on the agreed consideration, as announced on November 9, 2020, for the sale of 54% stake OTE holds in TKR to Orange Romania. Proceeds of the 30% sale will be added to TKR's balances and used in the ordinary course. Furthermore, the acquisition of this stake by OTE will have no material impact on the financial position of the Company. The net proceeds to OTE, after the cost of acquiring this 30%, transaction expenses, and required adjustments, will be returned to OTE shareholders in the form of extraordinary dividend and share buybacks as it has been already announced.

 

4) In conformity with all applicable legislation and regulation, the Company will make all necessary announcements to the investor community if and when relevant.

 

 

The European Commission's relevant Press Release is available on the below link:

Ø https://ec.europa.eu/commission/presscorner/detail/en/IP_21_3941

OTE's relevant announcements are available on the below link:

Ø https://www.cosmote.gr/cs/otegroup/en/nea_ependitikes_sxeseis.html

 

 

FOR FURTHER INFORMATION:

OTE GROUP INVESTOR RELATIONS

Tel.: +30 210 6118190

E-mail: iroffice@ote.gr

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RSPWPUBGMUPGURU
Date   Source Headline
19th Apr 20243:58 pmRNSPurchase of Own Shares
15th Apr 202412:06 pmRNSRelease date of Q1 2024 Financial Results
12th Apr 20243:55 pmRNSPurchase of Own Shares
2nd Apr 20247:00 amRNSPurchase of own shares
22nd Mar 20244:19 pmRNSPurchase of own shares
19th Mar 20248:01 amRNSPurchase of own shares
15th Mar 20241:13 pmRNSAnnouncement of regulated information
11th Mar 20248:48 amRNSAnnouncement of regulated information
8th Mar 20244:02 pmRNSPurchase of Own Shares
4th Mar 20248:15 amRNSPurchase of Own Shares
23rd Feb 20248:34 amRNSSBB 2024
22nd Feb 20243:08 pmRNSQ4 and FY2023 Financial Results
5th Feb 20241:06 pmRNSFinancial Calendar 2024
22nd Jan 202410:54 amRNSRelease date of Q42023 Financial Results
15th Dec 20238:13 amRNSAnnouncement Cancellation & Deletion of Shares
14th Dec 20234:17 pmRNSAnnouncement
5th Dec 20232:40 pmRNSVoting Results of OTE S.A. EGM of 30/11/2023
1st Dec 20237:57 amRNSPurchase of Own Shares
30th Nov 20233:04 pmRNSEGM Resolutions of 30.11.2023
24th Nov 20238:08 amRNSPurchase of Own Shares
21st Nov 20238:27 amRNSRegulated Information
17th Nov 20238:27 amRNSPurchase of Own Shares
14th Nov 20238:42 amRNSLiabre person’s transaction notification
10th Nov 20238:39 amRNSPurchase of Own Shares
9th Nov 20233:08 pmRNSInvitation of EGM
9th Nov 20238:41 amRNS3rd Quarter Results
3rd Nov 20238:29 amRNSPurchase of Own Shares
27th Oct 20238:05 amRNSPurchase Of Own Shares
20th Oct 20238:04 amRNSPurchase of Own Shares
13th Oct 20239:08 amRNSPurchase of Own Shares (Correct repetition)
13th Oct 20237:50 amRNSPurchase of Own Shares
12th Oct 20232:16 pmRNSMerger through absorption of Cosmote by OTE
10th Oct 202310:38 amRNSWrite-off of the unclaimed dividend of FY 2017
9th Oct 202312:38 pmRNSAnnouncement of Q3/2023 Results Release Date
6th Oct 20238:05 amRNSPurchase of Own Shares
29th Sep 20238:01 amRNSPurchase of Own Shares
22nd Sep 20237:24 amRNSPurchase of Own Shares
15th Sep 20237:52 amRNSPurchase of Own Shares
14th Sep 20234:28 pmRNSLiabre person’s transaction notification
8th Sep 20238:11 amRNSPurchase of Own Shares
1st Sep 20238:29 amRNSPurchase of Own Shares
25th Aug 20237:20 amRNSPurchase of Own Shares
22nd Aug 20238:14 amRNSPurchase of Own Shares
10th Aug 20234:51 pmRNSPurchase of own shares
4th Aug 20238:15 amRNSPurchase of own shares
3rd Aug 20238:55 amRNSFinancial Results Q2/2023
28th Jul 20237:22 amRNSPurchase of Own Shares
21st Jul 202310:51 amRNSPurchase of Own Shares
14th Jul 20239:29 amRNSCancellation & Deletion of Own Shares
14th Jul 20238:45 amRNSPurchase of Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.